Effects of Topical SLPI on Skin Wounds

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2000

Study Completion Date

July 31, 2003

Conditions
HealthyWound Healing
Interventions
DRUG

SLPI (Secretory Leukocyte Protease Inhibitor)

Trial Locations (1)

20892

National Institute of Dental And Craniofacial Research (NIDCR), Bethesda

All Listed Sponsors
lead

National Institute of Dental and Craniofacial Research (NIDCR)

NIH

NCT00005569 - Effects of Topical SLPI on Skin Wounds | Biotech Hunter | Biotech Hunter